Amedeo's Top 20

Amedeo Smart

Independent Medical Education


21 March 2016

Multidisciplinary Journal Club

  1. El-Serag HB, Kanwal F, Richardson P, Kramer J, et al.
    Risk of Hepatocellular Carcinoma after Sustained Virologic Response in Veterans with HCV-infection.
    Hepatology 2016.

  1. Stempel DA, Raphiou IH, Kral KM, Yeakey AM, et al.
    Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone.
    N Engl J Med 2016.

  2. Byrd-Leotis L, Galloway SE, Agbogu E, Steinhauer DA, et al.
    Influenza HA stem region mutations that stabilize or destabilize the structure of multiple HA subtypes.
    J Virol 2015.

  3. Kakuru A, Jagannathan P, Muhindo MK, Natureeba P, et al.
    Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy.
    N Engl J Med 2016;374:928-39.

  4. Perkin MR, Logan K, Tseng A, Raji B, et al.
    Randomized Trial of Introduction of Allergenic Foods in Breast-Fed Infants.
    N Engl J Med 2016.

  1. Orandi BJ, Luo X, Massie AB, Garonzik-Wang JM, et al.
    Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors.
    N Engl J Med 2016;374:940-50.

  2. Vasan SK, Rostgaard K, Majeed A, Ullum H, et al.
    ABO Blood Group and Risk of Thromboembolic and Arterial Disease: A Study of 1.5 Million Blood Donors.
    Circulation 2016.

  3. .
    Four Artemisinin-Based Treatments in African Pregnant Women with Malaria.
    N Engl J Med 2016;374:913-27.

  4. Choi J, Ghoz HM, Peeraphatdit T, Baichoo E, et al.
    Risk Factors for Cholangiocarcinoma: Aspirin-use and the Risk of Cholangiocarcinoma.
    Hepatology 2016.

  5. Majumder S, Chari ST.
    Chronic pancreatitis.
    Lancet 2016.

  1. Sumner T, Houben RM, Rangaka MX, Maartens G, et al.
    Post-Treatment Effect of Isoniazid Preventive Therapy on Tuberculosis Incidence in Hiv-Infected Individuals on Antiretroviral Therapy.
    AIDS 2016.

  2. Manas D, Burnapp L, Andrews PA.
    Summary of the British Transplantation Society UK Guidelines for Living Donor Liver Transplantation.
    Transplantation 2016.

  3. Kuan FC, Kuo LT, Chen MC, Yang CT, et al.
    Overall survival benefits of first-line EGFR tyrosine kinase inhibitors in EGFR-mutated non-small-cell lung cancers: a systematic review and meta-analysis.
    Br J Cancer 2015;113:1519-28.

  4. Jin X, Jones G, Cicuttini F, Wluka A, et al.
    Effect of Vitamin D Supplementation on Tibial Cartilage Volume and Knee Pain Among Patients With Symptomatic Knee Osteoarthritis: A Randomized Clinical Trial.
    JAMA 2016;315:1005-13.

  5. Berrigan LI, Fisk JD, Patten SB, Tremlett H, et al.
    Health-related quality of life in multiple sclerosis: Direct and indirect effects of comorbidity.
    Neurology 2016.

  1. Aspberg S, Chang Y, Atterman A, Bottai M, et al.
    Comparison of the ATRIA, CHADS2, and CHA2DS2-VASc stroke risk scores in predicting ischaemic stroke in a large Swedish cohort of patients with atrial fibrillation.
    Eur Heart J 2016.

  2. Bertuzzo VR, Cescon M, Odaldi F, Di Laudo M, et al.
    Actual Risk of Using Very Aged Donors for Unselected Liver Transplant Candidates: A European Single-center Experience in the MELD Era.
    Ann Surg 2016.

  3. Zhang T, Tremlett H, Leung S, Zhu F, et al.
    Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis.
    Neurology 2016.

  4. Bitzer M, Horger M, Giannini EG, Ganten TM, et al.
    Resminostat in combination with sorafenib as second-line therapy of advanced hepatocellular carcinoma - The SHELTER Study.
    J Hepatol 2016.

  5. Dad T, Tighiouart H, Joseph A, Bostom A, et al.
    Aspirin Use and Incident Cardiovascular Disease, Kidney Failure, and Death in Stable Kidney Transplant Recipients: A Post Hoc Analysis of the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial.
    Am J Kidney Dis 2016.


more..


Privacy Policy